FEEDBACK     HELP
WELCOME: Not Logged In HOME | MY ACCOUNT | ABOUT US | CONTACT US
SEARCH
ADVANCED
 SHOP OUR CATALOG
 JOURNALS
 Decker Intellectual Properties Websites >
 REGISTRATION
 FREE EMAIL TOC
 AUTHOR INFORMATION >
 FAQS
 CONFERENCES
 PERMISSION GUIDELINES
 SHIPPING INFORMATION
 PRIVACY POLICY
 ADVERTISERS INFORMATION >
 PHARMA SALES >
 DISTRIBUTION PARTNERS
External Access > PubMed LinkOut
ISSN Number: 1203-4754
Title: Journal of Cutaneous Medicine and Surgery
Volume Number: 17
Issue Number: 04
Page Number: 233
Published: 6 time(s) per Year

Therapy of Ulcerated Hemangiomas

Background:Cutaneous ulceration is the most common complication of infantile hemangiomas (IHs) seen in a pediatric dermatology practice.Objective:The most effective treatments in our experience are compared to those in the current literature.Methods:The study was a retrospective chart review of therapy of 169 ulcerated IHs at a tertiary care pediatric hospital and a literature review.Results:Combination therapy was the rule. Local wound care was required in all, pain management in 72%, pulsed dye laser in 42%, infection control in 38%, diminution of the hemangioma through systemic therapy in 36%, and suppression of bleeding in 2%.Limitations:A retrospective review compared to a case-control study has inherent bias. In addition, our cases were all at a tertiary referral center.Conclusion:All ulcerated IHs benefit from local barrier creams or dressings. Pulsed dye laser, antibiotics, topical morphine 0.1% in hydrogel, topical becaplermin, and, most importantly, systemic therapy (especially propranolol) to reduce the hemangioma may be useful.
Already A Subscriber?

PubMed Publication LinkOut Login
Username:   
Password:   

Non-Subscriber?

If you are not a current online subscriber to Journal of Cutaneous Medicine and Surgery then please click on the link below to purchase the article:

Buy Now!